10x Genomics, Inc.
TXG10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 6, 2026
4wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How TXG's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is 10x Genomics, Inc.'s next FDA catalyst?→
10x Genomics, Inc.'s (TXG) next tracked catalyst is a Earnings expected August 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TXG biotech catalysts?→
Add TXG to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow 10x Genomics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.